| Issue Date | Title | Author(s) |
| 2016 | Cardiovascular effects of an arginase II selective inhibitor | Yakushev, V. I.; Pokrovskii, M. V. |
| 2018 | Correction of retinal ischemia/reperfusion by 3-(1H-benzimidazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid in experiment | Peresypkina, A. A.; Levkova, E. A.; Yakushev, V. I.; Bunyatyan, N. D.; Churnosov, M. I. |
| 2017 | New Dosage Form of L-arginine based on its complex with cellulose acetate sulfate and activated carbon | Shakhno, E. A.; Savitskaya, T. A.; Pokrovskaya, T. G.; Yakushev, V. I.; Grinshpan, D. D. |
| 2017 | Physico-chemical properties of montmorillonite clays and their application in clinical practice (review) | Tishin, A. N.; Krut, U. A.; Tishina, O. M.; Beskhmelnitsyna, E. A.; Yakushev, V. I. |
| 2017 | Preclinical study of pharmacological activity of enterosorbente on the basis of montmorillonite | Tishin, A. N.; Tishina, O. M.; Yakushev, V. I.; Beskhmelnitsyna, E. A.; Linnik, M. S. |
| 2018 | Search and evaluation of pharmacodynamic and pharmacokinetic parameters of selective blocker of TRPA₁ ion channels from the group of substituted pyrazinopyrimidinones | Beskhmelnitsyna, E. A.; Dolzhikova, I. N.; Avtina, T. V.; Kulikov, A. L.; Rozhnova, D. V.; Yakushev, V. I.; Martynov, M. A. |
| 2016 | Studying dose-dependent endothelio- and cardioprotective activity of selective arginase II inhibitor in hyperhomocysteineinduced endothelial dysfunction | Yakushev, V. I.; Filippenko, N. G.; Kizilova, I. V.; Korokin, M. V.; Beskhmelnitsyna, E. A. |
| 2016 | Use of L-arginine immobilised on activated carbon for pharmacological correction of endothelial disfunction | Shakhno, E. A.; Savitskaya, T. A.; Pokrovskaya, T. G.; Yakushev, V. I.; Pokrovskii, M. V. |
